Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Change in Cash (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Change in Cash for 4 consecutive years, with $38.2 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 279.5% to $38.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.2 million through Dec 2025, up 117.63% year-over-year, with the annual reading at $10.2 million for FY2025, 117.63% up from the prior year.
  • Change in Cash for Q4 2025 was $38.2 million at Spruce Biosciences, up from -$5.7 million in the prior quarter.
  • The five-year high for Change in Cash was $49.2 million in Q1 2023, with the low at -$25.6 million in Q3 2022.
  • Average Change in Cash over 4 years is $373625.0, with a median of -$7.5 million recorded in 2025.
  • The sharpest move saw Change in Cash surged 353.66% in 2023, then crashed 829.95% in 2024.
  • Over 4 years, Change in Cash stood at $2.9 million in 2022, then tumbled by 185.84% to -$2.5 million in 2023, then crashed by 765.58% to -$21.3 million in 2024, then skyrocketed by 279.5% to $38.2 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $38.2 million, -$5.7 million, and -$9.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.